Sensitivity and specificity of ropivacaine combined with sufentanil in optimized epidural test dose

Sensitivity and specificity of ropivacaine 5mg combined with sufentanil 2.5µg in optimized epidural test dose in obstetrics

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000035963

Enrollment

Unknown

Registered

2020-08-20

Start date

2020-08-19

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrathecal anesthesia

Interventions

IT:Intrathecal injection

EP:Epidural administration

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Parturients (ASA II) underwent epidural labor analgesia.

Exclusion criteria

Exclusion criteria: 1. Patients allergic to local anesthetics; 2. Patients with absolute and relative contraindications of intraspinal block; 3. Patients with diabetes mellitus, liver and kidney dysfunction, heart disease, mental illness, and those who cannot cooperate, 4. Drug users, long-term opioid dependence patients; 5. Sedative analgesics and antiemetic drugs were used 24 hours before operation, and the patients were in shock.

Design outcomes

Primary

Measure	Time frame
The level of sensory block;Symptom of warmth and numbness;	—

Secondary

Measure	Time frame
motor block;	—

Countries

China

Contacts

Public ContactYue Li

Obstetrics and Gynecology Hospital of Fudan University

13918324826@163.com+86 13918324826

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026